MarkMonitor®, the global leader in enterprise brand protection, released the Summer 2008 Brandjacking Index™, reporting that brandjackers increasingly abuse top-ranked pharmaceutical brands, endangering consumers via a supply chain compromised by the sale of questionable prescription drugs through dubious online pharmacies and exchange sites.
Lees meer..

A day after it halted clinical trials on its prostate cancer drug and saw its stock plummet 72 percent, Cell Genesys Inc. got a hint of relief. (CEGE)

Lees meer..

Affymax Inc. and Takeda Pharmaceutical Company Ltd. said Thursday they agreed to suspend co-development of Hematide for treatment of chemotherapy-induced anemia and instead focus all development efforts for the drug on the treatment of chronic kidney disease related anemia. (AFFY)

Lees meer..

HemCon Medical Technologies Inc. on Thursday announced an exclusive licensing agreement with Institute of Technology Sligo of Ireland to develop new antibacterial technology.

Lees meer..

The Securities and Exchange Commission on Monday said it revoked the public stock registrations of Plantation-based Viragen (Pink Sheets: VRAI) and Viragen International (Pink Sheets: VRGE) for failure to file their required periodic reports.

Lees meer..

GlaxoSmithKline has signed a drug development deal worth as much as $820 million with California company Valeant Pharmaceuticals International, the companies said Thursday. (VRX) (GSK)

Lees meer..

A drug Curis Inc. helped develop as a potential cancer treatment through contribution of some intellectual property will begin a midstage human clinical trial. (DNA)

Lees meer..

Valeant Pharmaceuticals International has entered a collaboration agreement with GlaxoSmithKline for the investigational drug retigabine, a neuronal potassium channel opener for treatment of adult epilepsy patients, the companies said Thursday. (VRX)

Lees meer..

AmeriStart has signed a sales, marketing and business-development contract with Factory CRO, a Dutch clinical research organization that conducts medical-device studies for regulatory approval.

Lees meer..

Audience: Emergency healthcare professionals, military emergency/disaster/field hospital/aviation personnel [Posted 08/28/2008] Pacific Consolidated Industries, LLC, and FDA notified healthcare professionals of the Class I Recall of the Mobile…
Audience: Emergency healthcare professionals, military emergency/disaster/field hospital/aviation personnel [Posted 08/28/2008] Pacific Consolidated Industries, LLC, and FDA notified healthcare professionals of the Class I Recall of the Mobile…
Lees meer..